Cohen Yuval

Chief Executive Officer

Cohen Yuval has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.

On the most recent filing, Cohen Yuval is listed as Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Cohen Yuval reported no open-market purchases and 2 open-market sales totaling $279K in CRBP. The largest disclosed transaction in the window is a sale of 17,000 CRBP shares on Aug 7, 2026, worth $171K.

Companies traded

Other insiders at CRBP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$279K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CRBPSale$171KAug 10SEC ↗
CRBPSale$108KFeb 18SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 27, 2025CRBPSale$154K
Oct 24, 2025CRBPSale$317K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Cohen Yuval made?

Cohen Yuval has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Cohen Yuval trade?

Cohen Yuval has filed SEC Form 4 disclosures for 1 company, including CRBP.

When was Cohen Yuval's most recent SEC Form 4 filing?

Cohen Yuval's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.

What is Cohen Yuval's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Cohen Yuval is listed as Chief Executive Officer.

What is Cohen Yuval's total buy and sell value in the current window?

Inside the rolling retention window, Cohen Yuval bought $0 and sold $279K based on SEC Form 4 filings.

What was Cohen Yuval's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 17,000 CRBP shares on 2026-08-07, worth $171K, per SEC Form 4 filings.